This is a randomized trial investigating whether continuous norepinephrine administration via an infusion pump - compared to manual bolus administration - increases blood pressure stability within the first 15 minutes of anesthetic induction in non-cardiac surgery patients. The secondary endpoints area under a MAP of 65, 60, 50, and 40 mmHg \[mmHg × min\], cumulative duration of a MAP \<65, \<60, \<50, and \<40 mmHg \[min\], area above a MAP of 100, 110, 120, and 140 mmHg \[mmHg min\], cumulative duration of a MAP \>100, \>110, \>120, and \>140 mmHg \[min\] and cumulative dose of norepinephrine indexed to body weight \[μg/kg\] within the first 15 minutes of anesthetic induction will be assessed.
not provided
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
72
Patients will be randomized 1:1 to continuous norepinephrine infusion via an infusion pump or to manual bolus norepinephrine administration. The norepinephrine dose will be at the discretion of the treating anesthesiologists.
Patients will be randomized 1:1 to continuous norepinephrine infusion via an infusion pump or to manual bolus norepinephrine administration. The norepinephrine dose will be at the discretion of the treating anesthesiologists.
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Blood pressure stability
Generalized average real variability (gARV) of mean arterial pressure (MAP) within the first 15 minutes of anesthetic induction \[mmHg/min\]; the gARV is the sum of absolute values of the differences between neighboring measurements for all measurements divided by the total measurement duration in \[mmHg/min\].
Time frame: Measurement period of 15 minutes starting at the beginning of the anesthetic induction
Area under MAP
Area under a MAP of 65, 60, 50, and 40 mmHg \[mmHg × min\]. MAP will be measured using intraarterial blood pressure monitoring.
Time frame: Measurement period of 15 minutes starting at the beginning of the anesthetic induction
Cumulative duration of a MAP below
Cumulative duration of a MAP \<65, \<60, \<50, and \<40 mmHg \[min\]. MAP will be measured using intraarterial blood pressure monitoring.
Time frame: Measurement period of 15 minutes starting at the beginning of the anesthetic induction
Area above MAP
Area above a MAP of 100, 110, 120, and 140 mmHg \[mmHg × min\]. MAP will be measured using intraarterial blood pressure monitoring.
Time frame: Measurement period of 15 minutes starting at the beginning of the anesthetic induction
Cumulative duration of a MAP above
Cumulative duration of a MAP \>100, \>110, \>120, and \>140 mmHg \[min\]. MAP will be measured using intraarterial blood pressure monitoring.
Time frame: Measurement period of 15 minutes starting at the beginning of the anesthetic induction
Cumulative dose of norepinephrine
Cumulative dose of norepinephrine indexed to body weight \[μg/kg\]
Time frame: Measurement period of 15 minutes starting at the beginning of the anesthetic induction
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.